H19 and hepatocellular carcinoma: Furthermore, Gamaev et al. [12] demonstrated that in the Mdr2-KO mouse model, the lncRNA-H19 acts as a pro-oncogene throughout the progression of chronic inflammation-induced HCC, primarily by escalating liver damage and lowering hepatocyte polyploidy in young mice.